Sarepta Therapeutics Inc. logo

Sarepta Therapeutics Inc.

SRPT | NASDAQ
Chart Builder DCF Calculator
$20.12
+$0.01 (+0.05%)
At close: Sep 21, 2026, 4:00 PM ET
$20.06
-$0.06 (-0.30%)
Pre-market: Sep 22, 2026, 4:42 AM ET

Market Data

Market Cap
$2.12B
Enterprise Value
$2.38B
Beta
0.21
Average Volume
3.25M
Shares Outstanding (Diluted)
105.43M
Shares Change YoY
-1.12%
Institutional Ownership
98.04%
Exchange
NASDAQ
ISIN
US8036071004

Price Performance

Price Change 1M
8.4%
Price Change 3M
16.6%
Price Change 6M
-15.4%
Price Change YTD
-5.6%
Price Change 1Y
7.9%
Price Change 3Y
-83.2%
Price Change 5Y
-77.8%
1M CAGR (ann.)
19.9%
1Y CAGR (ann.)
17.9%
5Y CAGR (ann.)
-24.2%
All-Time CAGR
-1.2%

Valuation

PE Ratio
-6.94
Forward PE
25.45
PEG Ratio
0.02
Forward PEG
0.18
PS Ratio
1.08
Forward PS
1.50
PB Ratio
1.39
P/FCF Ratio
-16.16
P/Adj. FCF Ratio
-8.18
P/OCF Ratio
-23.13
EV/Sales
1.21
EV/EBIT
-40.17
EV/EBITDA
-163.31
EV/FCF
-18.12
Earnings Yield
-14.4%
FCF Yield
-6.2%
Adj. FCF Yield
-12.2%

Financial Health

Net Debt
$59.13M
Total Debt
$1.05B
Cash & Short-Term Investments
$788.49M
Total Assets
$3.19B
Current Ratio
4.42
Quick Ratio
2.62
Debt / Equity Ratio
0.68
Debt / EBITDA
-71.71
Debt / FCF
-7.96
OCF / Debt
-0.09
Interest Coverage
-2.45
Altman Z-Score
-0.03
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
58.6%
Operating Profit Margin
-7.3%
EBITDA Margin
-0.7%
Net Profit Margin
-6.9%
FCF Margin
-6.7%
Adj. FCF Margin
-13.2%
SBC / Revenue
6.5%
SBC Impact (per share)
-97.5%

Returns

Return on Assets
-4.3%
Return on Equity
-10.0%
Return on Invested Capital
-5.3%
Return on Capital Employed
-5.3%
Return on Tangible Assets
-4.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
25.3%
Revenue CAGR 5Y
26.9%
Revenue CAGR 10Y
108.8%
EPS CAGR 3Y
-147.3%
EPS CAGR 5Y
39.4%
EPS CAGR 10Y
6.0%
FCF CAGR 3Y
53.4%
FCF CAGR 5Y
12.8%
FCF CAGR 10Y
-2.6%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
55
EPS Growth Next 3Y
53.7%
Revenue Growth Next 3Y
-12.8%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$23.33
Price Target Upside
16.0%

Cash Flow

Operating Cash Flow
$-91.68M
Free Cash Flow
$-131.47M
Adj. Free Cash Flow
$-259.68M
FCF Per Share
-$1.25
OCF Per Share
-$0.87
OCF/S Ratio
-4.6%

Income Statement

Revenue
$1.97B
Gross Profit
$1.16B
Operating Income
$-143.25M
EBITDA
$-14.58M
Net Income
$-136.73M
EPS (Diluted)
-$2.90
Revenue / Employee
$2.36M
Profit / Employee
$-163.74K
Employees
835

© 2026 bestshares.com. All rights reserved.